The Clustering of mApoE Anti-Amyloidogenic Peptide on Nanoparticle Surface Does Not Alter Its Performance in Controlling Beta-Amyloid Aggregation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Clustering of mApoE Anti-Amyloidogenic Peptide on Nanoparticle Surface Does Not Alter Its Performance in Controlling Beta-Amyloid Aggregation
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 3, Pages 1066
Publisher
MDPI AG
Online
2020-02-06
DOI
10.3390/ijms21031066
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Extent of Human Apolipoprotein A-I Lipidation Strongly Affects the β-Amyloid Efflux Across the Blood-Brain Barrier in vitro
- (2019) Roberta Dal Magro et al. Frontiers in Neuroscience
- Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease
- (2019) Jyoti Gupta et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Evolution of Nanoparticle Protein Corona across the Blood–Brain Barrier
- (2018) Alysia Cox et al. ACS Nano
- Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region
- (2018) Mukta Agrawal et al. Expert Opinion on Drug Delivery
- Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer’s Disease
- (2018) Eleanor Drummond et al. JOURNAL OF ALZHEIMERS DISEASE
- Impact of nanoparticles on amyloid peptide and protein aggregation: a review with a focus on gold nanoparticles
- (2018) Torsten John et al. Nanoscale
- Microfluidic deposition for resolving single-molecule protein architecture and heterogeneity
- (2018) Francesco Simone Ruggeri et al. Nature Communications
- The interaction of lipid-liganded gold clusters (Aurora ™) with lipid bilayers
- (2018) Jesús Sot et al. CHEMISTRY AND PHYSICS OF LIPIDS
- Structural Optimization of Foldamer-Dendrimer Conjugates as Multivalent Agents against the Toxic Effects of Amyloid Beta Oligomers
- (2018) Éva Bartus et al. MOLECULES
- Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015
- (2017) Dev Mehta et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier
- (2017) R. Dal Magro et al. JOURNAL OF CONTROLLED RELEASE
- Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes
- (2016) Luca Nardo et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Effects of cytosine methylation on DNA morphology: An atomic force microscopy study
- (2016) V. Cassina et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Automated Analysis of Orientational Order in Images of Fibrillar Materials
- (2016) Nils E. Persson et al. CHEMISTRY OF MATERIALS
- The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease
- (2016) Simona Mancini et al. Nanomedicine-Nanotechnology Biology and Medicine
- The unfolded protein response in neurodegenerative diseases: a neuropathological perspective
- (2015) Wiep Scheper et al. ACTA NEUROPATHOLOGICA
- Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood–brain-barrier: Implications for therapy of Alzheimer disease
- (2013) Laura Bana et al. Nanomedicine-Nanotechnology Biology and Medicine
- Nanoparticle accumulation and transcytosis in brain endothelial cell layers
- (2013) Dong Ye et al. Nanoscale
- Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model
- (2011) Francesca Re et al. Nanomedicine-Nanotechnology Biology and Medicine
- Lipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptide
- (2010) Marco Gobbi et al. BIOMATERIALS
- Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimers Disease
- (2010) F. Re et al. CURRENT MEDICINAL CHEMISTRY
- Stability of Aβ (1-42) peptide fibrils as consequence of environmental modifications
- (2010) Maria Gregori et al. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- Atomic force microscopy study of DNA conformation in the presence of drugs
- (2010) Valeria Cassina et al. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- Multivalent & Multifunctional Ligands to β-Amyloid
- (2009) YoungSoo Kim et al. CURRENT PHARMACEUTICAL DESIGN
- Picomolar Amyloid- Positively Modulates Synaptic Plasticity and Memory in Hippocampus
- (2009) D. Puzzo et al. JOURNAL OF NEUROSCIENCE
- Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
- (2009) Juha Laurén et al. NATURE
- Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Aβ assembly forms throughout life
- (2009) Ganesh M. Shankar et al. NEUROBIOLOGY OF DISEASE
- Designing Peptide Inhibitors for Oligomerization and Toxicity of Alzheimer's β-Amyloid Peptide†
- (2008) Brian M. Austen et al. BIOCHEMISTRY
- Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
- (2008) Melanie Meyer-Luehmann et al. NATURE
- Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles
- (2008) Ayush Verma et al. NATURE MATERIALS
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- Atomic force microscopy as a multifunctional molecular toolbox in nanobiotechnology
- (2008) Daniel J. Müller et al. Nature Nanotechnology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started